Geneva, Switzerland, July 8, 2026-Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric ...
Geneva, Switzerland, April 19, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that ...
Ad Hoc Announcement Pursuant to Art. 53 LRGeneva, Switzerland, June 30, 2026-Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage ...
Geneva, Switzerland, August 15, 2022 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today ...
Geneva, Switzerland, April 23, 2026-Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric ...
Tuesday, Addex Therapeutics Ltd (NASDAQ:ADXN) stock is trading higher with a session volume of 3.79 million versus the average volume of 4.16K as per data from Benzinga Pro. Addex Therapeutics and ...
Addex Therapeutics' Phase 2 study missed statistical significance for patients to reach baseline seizure count for ADX71149 plus SoC. The company will complete the analysis and work with the partner ...
Addex's Gen 3 EGC (External Gauge Control) introduces "Intensive Cooling" as a cutting-edge retrofit solution for blown film plastic lines featuring rotating dies, showcased at NPE2024 in Orlando, FL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results